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The stimulation of glucose uptake by insulin in muscle and
adipose tissue requires translocation of the GLUT4 glucose trans-
porter protein from intracellular storage sites to the cell sur-
face1±6. Although the cellular dynamics of GLUT4 vesicle
traf®cking are well described, the signalling pathways that link
the insulin receptor to GLUT4 translocation remain poorly under-
stood. Activation of phosphatidylinositol-3-OH kinase (PI(3)K) is
required for this traf®cking event, but it is not suf®cient to
produce GLUT4 translocation7. We previously described a path-
way involving the insulin-stimulated tyrosine phosphorylation of
Cbl, which is recruited to the insulin receptor by the adapter
protein CAP8,9. On phosphorylation, Cbl is translocated to lipid
rafts. Blocking this step completely inhibits the stimulation of
GLUT4 translocation by insulin10. Here we show that phos-
phorylated Cbl recruits the CrkII±C3G complex to lipid rafts,
where C3G speci®cally activates the small GTP-binding protein
TC10. This process is independent of PI(3)K, but requires the
translocation of Cbl, Crk and C3G to the lipid raft. The activation
of TC10 is essential for insulin-stimulated glucose uptake and
GLUT4 translocation. The TC10 pathway functions in parallel
with PI(3)K to stimulate fully GLUT4 translocation in response to
insulin.
Many receptor tyrosine kinases use small GTP-binding proteins
as molecular switches to convert proximal tyrosine phosphorylation
into the activation of serine/threonine kinase cascades11. In
addition, small GTP-binding proteins are critical for intracellular
vesicle traf®cking12. We have examined the modulation of insulin-
stimulated glucose uptake and GLUT4 translocation by several
small GTP-binding proteins1. Expression of wild-type, dominant-
interfering and constitutively active mutants of Ras, Rap1, Rac1,
TC21, RhoA and RhoD in 3T3L1 adipocytes had no discernible
effect on this biological response (data not shown). In contrast,
expression of wild-type TC10 (TC10/WT) and a dominant-inter-
fering TC10 mutant (TC10/T31N) signi®cantly inhibited insulin-
stimulated glucose uptake (Fig. 1a).
As the transfection ef®ciency was about 50%, it is likely that
expression of the TC10/T31N mutant almost completely inhibited
glucose uptake in the transfected cell population. Out of the known
GTP-binding proteins, Cdc42 has the greatest degree of sequence
similarity to TC10, with an overall sequence identity of 69% and
similarity of 83%. However, expression of wild-type Cdc42 (Cdc42/
WT) or the dominant-interfering Cdc42 mutant (Cdc42/T17N)
had no statistically signi®cant effect on insulin-stimulated glucose
uptake (Fig. 1a).
To determine whether TC10 inhibits insulin-stimulated glucose
uptake through a blockade of GLUT4 translocation, we micro-
injected 3T3L1 adipocytes along with expression plasmids for TC10
or Cdc42 (Fig. 1b). The cells were microinjected with the carboxy-
terminal domain of Ras fused to the maltose-binding protein
(MBP±Ras) as a marker for plasma-membrane in injected cells2±4.
As GLUT4 is localized predominantly in intracellular vesicles in the
basal state, there is only a low level of GLUT4 immuno¯uorescence
in the plasma-membrane sheets derived from both the micro-
injected and non-microinjected cells. As typically observed, insulin
produced the robust appearance of plasma-membrane GLUT4
immuno¯uorescence in both the microinjected and surrounding
non-injected cells. Microinjection of either TC10/WT or TC10/
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Figure 1 Expression of TC10 inhibits insulin-stimulated glucose uptake and GLUT4
translocation in 3T3L1 adipocytes. a, Differentiated 3T3L1 adipocytes were transfected
with TC10 and Cdc42 mutants. The cells were left untreated or were stimulated with
100 nM insulin for 30 min. The rate of [3H]2-deoxyglucose (2-DG) uptake was
determined. Results are the mean 6 s.e. of 3±5 independent experiments from individual
experiments performed in triplicate with a transfection ef®ciency of ,50%. Two asterisks,
P , 0.01. b, Differentiated 3T3L1 adipocyte nuclei were microinjected with 0.2 mg ml-1
of MBP±Ras plus either the empty vector or the cDNAs encoding TC10/WT, TC10/T31N,
CDC42/WT or CDC42/T17N. The cells were allowed to recover for 24 h, and left untreated
or treated with 100 nM insulin for 30 min.
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comparison to the surrounding non-injected cells. Microinjection
of Cdc42/WT or Cdc42/T17N had no signi®cant effect on insulin-
stimulated GLUT4 translocation. We scored 30±60 plasma-
membrane sheets per condition from 4 independent experiments,
which showed that the complementary DNAs for TC10/WT, TC10/
T31N, Cdc42/WT and Cdc42/T17N inhibited insulin-stimulated
GLUT4 translocation in 66 6 8, 75 6 8, 7 6 3 and 8 6 4% of the
microinjected 3T3L1 adipocytes, respectively.
As a control for GLUT4 translocation speci®city, we also
examined the effect of TC10 and Cdc42 expression on insulin-
stimulated GLUT1 translocation (Supplementary Information
Fig. 1). Although insulin has a more modest effect on the trans-
location of GLUT1 as compared with GLUT4 (refs 5, 6), micro-
injection of both the TC10 and Cdc42 cDNAs had no effect.
To con®rm the effect of TC10 on GLUT4 translocation, we co-
expressed TC10 with a GLUT4±enhanced green ¯uorescent protein
(EGFP) fusion construct in 3T3L1 adipocytes (Supplementary
Information Fig. 2). Co-expression of GLUT4±EGFP with TC10/
WT or TC10/T31N markedly decreased the number of the cells
responding to insulin. In contrast, overexpression of Cdc42/WT or
Cdc42/T17N had no effect on insulin-stimulated GLUT4±EGFP
translocation. In addition, expressing the constitutively active
mutant TC10/Q75L and GTP-cycling mutant TC10/F42L resulted
in a substantial inhibition of insulin-stimulated GLUT4 transloca-
tion. As a measure of GLUT4 vesicle speci®city, expression of TC10
or Cdc42 had no signi®cant effect on the insulin-stimulated
translocation of the cation-independent mannose-6-phosphate
receptor (data not shown).
The inhibition of insulin-stimulated glucose uptake and GLUT4
translocation through overexpression of the TC10/T31N dominant-
interfering mutant is consistent with its role as a signalling inter-
mediate; however, it was surprising that overexpression of the wild-
type TC10 protein also inhibited this biological response. TC10 has
a lower intrinsic GTPase activity than has Cdc42 (ref. 13). If a
GTPase-activating activity limits the process, overexpression of
TC10 would cause increased basal TC10-GTP, and thus behave
like a constitutively active mutant. Indeed, both constitutively active
and dominant-negative rhoA or Rac1 proteins perturbed tight
junction gate function14. Thus, the overexpressed mutant GTPases
might displace cycling endogenous GTPases from targets. As
mutant proteins remain bound to the effectors, overexpression
results in quick domination of the mutant phenotype. Overexpres-
sing wild-type TC10 may alter binding stoichiometry and/or mis-
target the effectors to wrong locations and thereby prevent the
appropriate propagation of the signal.
Several studies have shown that in the active (GTP-bound) con-
a
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Figure 2 Insulin activates TC10 through a PI(3)K-independent pathway in 3T3L1
adipocytes. a, Fully differentiated 3T3L1 adipocytes were electroporated with 60 mg of a
cDNA encoding HA-tagged TC10. Cells were starved for 3 h before treatment with 100 nM
insulin. Bottom, lysates from different time points were immunoblotted with anti-HA
antibody. Top, lysates were incubated with GST±Pak1 for 1 h, followed by 3 washes and
immunoblotted with anti-HA (top). b, 3T3L1 adipocytes were electroporated with
HA-tagged TC10, incubated for 30 min with increasing doses of wortmannin (WM;
0±100 nM), and treated with insulin for 5 min. Top, GST±Pak1 pull-down assay probed
with anti-HA. Middle, anti-HA immunoblots with lysates from different treatments. Bottom,
phospho-Akt blot with the same lysates.




Insulin      0  1  2  5 10
 (min)
TC10









0 1 3 5 15  30
C3G
CavI





























Figure 3 TC10 is activated by insulin through a CAP-dependent pathway. a, 3T3L1
adipocytes were co-electroporated with 60 mg of HA±TC10 and 500 mg of LacZ control,
or Flag-tagged CAP or CAPDSH3. Cells were starved for 3 h before collection. Top, HA
immunoblot of pull-down samples from different time points. Bottom, HA and Flag
immunoblots with 50 mg of lysate. b, 3T3L1 adipocytes were treated with 100 nM insulin
for various times. Cells were lysed at 4 8C in the presence of Triton X-100. Triton-insoluble
complexes were prepared10, and 20 mg of the triton-insoluble material was suspended in
Laemmli sample buffer, separated by SDS±PAGE, transferred to nitrocellulose and
blotted for C3G, CRKII, caveolin I (Cav1) and ¯otillin. c, 3T3L1 adipocytes were transfected
by electroporation with LacZ, CAP or CAPDSH3, and stimulated with 100 nM insulin for
5 min. The transfection ef®ciency was 50%. Cells were lysed at 4 8C in the presence of
TritonX-100. Triton-insoluble complexes were suspended in sample buffer, resolved by
SDS±PAGE, transferred to nitrocellulose and immunoblotted with anti-C3G and caveolin I
antibodies. A representative blot is shown. Films were scanned and quanti®ed, and the
ratio of total C3G to caveolin I was calculated. Two asterisks, P , 0.01; n = 4.
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formation, Rac and Cdc42 associate speci®cally with the Cdc42/Rac
interactive binding (CRIB) motif of the p21-activated protein kinase
1, Pak1 (refs 15±17). TC10 also binds the CRIB domain of effector
proteins in a GTP-dependent manner13. To con®rm that the Pak1
CRIB domain speci®cally interacts with these proteins, we trans-
fected Chinese hamster ovary (CHO) cells with HA-epitope tagged
wild-type Rac1, Cdc42 or TC10 cDNAs (Supplementary Informa-
tion Fig. 3). The extracts were incubated with GDP or GTP-gS, and
precipitated with a gluthathione S-transferase (GST)±Pak1 fusion
protein. The fusion protein quantitatively precipitated the GTPgS-
bound forms of Rac, Cdc42 or TC10, showing that GST±Pak1
speci®cally recognizes the GTP-bound, activated state of these Rho
family GTPases.
To examine whether TC10 can be activated in 3T3L1 adipocytes,
we electroporated cells with a cDNA encoding HA±TC10 and
treated them with insulin (Fig. 2a). Treating the cells with insulin
caused the activation of TC10, which was maximal by about 5 min
and declined thereafter. The activation of TC10 by insulin was
speci®c, as insulin had no effect on GTP loading of Cdc42 (Supple-
mentary Information Fig. 4). To determine whether activation of
TC10 is unique for insulin, we treated HA±TC10-electroporated
cells with platelet-derived growth factor (PDGF). In contrast to
insulin, TC10 was not activated by PDGF (Supplementary Informa-
tion Fig. 5). Together, these data provide strong evidence that TC10
is activated by insulin through a speci®c and unique signalling
pathway.
Several studies have shown that PI(3)K activation is necessary,
but not suf®cient for insulin-stimulated GLUT4 translocation18±20.
To determine whether TC10 activation requires PI(3)K, 3T3L1
adipocytes were electroporated with HA±TC10, followed by incu-
bation with increasing doses of wortmannin, a PI(3)K inhibitor.
Cells were then stimulated with insulin, and lysates were analysed
for Akt phosphorylation and TC10 activation. The stimulation of
Akt phosphorylation by insulin was completely blocked by incuba-
tion with wortmannin21,22 (Fig. 2b). In contrast, TC10 activation was
unaffected by wortmannin, indicating that TC10 activation does
not occur downstream of PI(3)K.
We have reported that the insulin-stimulated tyrosine phos-
phorylation of Cbl results in its recruitment to ¯otillin-enriched
plasma-membrane subdomains through the adapter protein
CAP10. Expression of a dominant-interfering CAP mutant
(CAPDSH3) has no effect on PI(3)K activation, but prevents the
recruitment of tyrosine-phosphorylated Cbl to lipid rafts, and
concomitantly inhibits insulin-stimulated glucose uptake and
GLUT4 translocation10. To assess the potential role of the CAP±
Cbl complex in TC10 activation, we co-transfected 3T3L1 adipo-
cytes with HA±TC10 and either wild-type CAP or CAPDSH3
(Fig. 3a). The insulin-stimulated activation of TC10 was unaffected
by the co-expression of the wild-type CAP protein; however,
expression of CAPDSH3 slightly reduced the basal level of activated
TC10, and completely prevented the insulin-stimulated increase in
TC10 GTP loading. These data show that the CAP±Cbl axis
provides a necessary signal parallel to the PI(3)K pathway for the
activation of TC10 by insulin.
Stimulation of the tyrosine phosphorylation of Cbl by insulin
generates a speci®c docking site for the amino-terminal Src homol-
ogy (SH)-2 domain of the small adapter protein CrkII (ref. 8).
Furthermore, the SH3 domain of CrkII interacts directly with the
proline-rich domain of the guanyl nucleotide exchange factor
C3G23. As tyrosine-phosphorylated Cbl is translocated into lipid
rafts in response to insulin, we thought that Cbl might also recruit
the CrkII±C3G complex into this plasma-membrane region. To test
this possibility, 3T3L1 adipocytes were stimulated with insulin, and
the lipid raft plasma-membrane domain was isolated as a Triton X-
100 insoluble fraction (Fig. 3b). Immunoblotting with an anti-
caveolin antibody showed that caveolin I and ¯otillin were found
in the Triton-insoluble fraction, and that their distribution was
unaffected by insulin. In contrast, both CrkII and C3G migrated in
the Triton-soluble fraction, but were recruited into the Triton-
insoluble faction in response to insulin. This effect was maximal at
3 min, and was reversed by 30 min. The time course of CrkII and
C3G movement to the Triton-insoluble fraction paralleled the
insulin-stimulated recruitment of Cbl10 and the activation of
TC10 (Fig. 2). As a control, insulin had no effect on the subcellular
localization of the Ras nucleotide exchange factor SOS. This protein
was found largely in the Triton-soluble fraction, but small amounts
could be seen in the insoluble fraction on overexposure of the gels.
Furthermore, the translocation of neither CrkII nor C3G was
affected by pretreatment of cells with wortmannin (data not
shown).
As expression of the dominant-interfering mutant CAPDSH3
prevented the recruitment of tyrosine-phosphorylated Cbl to the
caveolin/¯otillin-enriched subdomain10, we evaluated its effect on
the recruitment of C3G to the Triton-insoluble complex (Fig. 3c).
Insulin stimulated a marked recruitment of C3G into the Triton-
insoluble fraction in both LacZ- and CAP-expressing cells; however,
expression of CAPDSH3 decreased the insulin-stimulated recruit-
ment of C3G by roughly 40%. Taking into account a 50% transfec-
tion ef®ciency, this corresponds to a near complete block of C3G
recruitment in the transfected cell population. Thus, insulin stimu-
lates the translocation of C3G into caveolin-enriched compart-
ments through a process that requires CAP function.







































Figure 4 C3G catalyses guanine nucleotide exchange for TC10. a, 293T cells were
transfected with constructs encoding Myc±C3G and Flag±SOS. Cells were immuno-
precipitated with anti-Flag or anti-Myc antibodies, and immunoprecipitates were assayed
for exchange activity using GST fusion proteins of [3H]GDP-loaded TC10, cdc42, Rap1a
and Ras in the presence of GTP. Aliquots were withdrawn at various time points and
scintillation counting was performed. Results are the mean 6 s.e. of triplicate
determinations and are representative of three experiments. b, 3T3L1 adipocytes were
co-electroporated with HA±TC10 and 200 mg of a LacZ control or a C3G expression
vector. Top, HA immunoblot of pull-down samples from different time points. Bottom, HA
and C3G immunoblots with 50 mg of lysate.
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of C3G recruitment implicates C3G as a possible insulin-regulated
guanyl nucleotide exchange factor (GEF) for TC10. To assess the
relative GEF activity of C3G for TC10, both C3G and SOS were
expressed in 293T cells, and immunoprecipitation was carried out.
GTP-loading assays were performed on the immunoprecipitates
using Ras, Rap1 or TC10 as substrate (Fig. 4a). As previously
reported24, SOS had a relatively high activity for Ras, but was a
poor GEF for Rap1. In contrast, C3G effectively catalysed the
exchange of GTP for GDP on Rap1, but was ineffective with Ras.
SOS was also a very weak GEF for TC10, whereas C3G displayed
profound GTP/GDP exchange activity for TC10. However, C3G did
not show exchange activity with Cdc42 as substrate.
To examine the speci®c exchange activity of C3G for TC10, we
deleted the putative GEF catalytic domain that exhibits sequence
similarity to the Saccharomyces cerevisiae CDC25 exchange factor
(C3GDcdc25). The C3GDcdc25 mutant failed to exchange GTP for
GDP on Rap1 as well as TC10 (Supplementary Information Fig. 6).
Thus, C3G can function as a speci®c GEF for TC10 in vitro, with
activity comparable to that seen with its established target Rap1.
To determine whether C3G can function as a TC10 GEF in vivo,
we co-transfected 3T3L1 adipocytes with HA±TC10 either with or
without an expression vector encoding C3G (Fig. 4b). Transfection
with C3G cDNA resulted in a marked increase in C3G protein over
endogenous levels, but did not signi®cantly affect the co-expression
of HA±TC10. In the absence of C3G overexpression, TC10 was
predominantly in the inactive GDP-bound state, but was activated
in response to insulin. In cells overexpressing C3G, however, TC10
was quantitatively converted to the active GTP-bound state in the
absence of insulin. Under these conditions, TC10 was activated
maximally, as insulin did not further increase the amount of GTP-
bound TC10.
The activation of TC10 by wild-type C3G suggests that over-
expression of C3G may result in its being targeted to lipid rafts in an
insulin-independent manner. Consistent with this hypothesis, a
signi®cant fraction of the wild-type C3G was detected in the Triton-
insoluble fraction, although most of the overexpressed C3G protein
was cytosolic (Supplementary Information Fig. 7). Thus, the excess
expression of wild-type C3G results in its hormone-independent
mistargeting to lipid rafts, where it can catalyse nucleotide exchange
on TC10.
Although our data suggest that TC10 activation provides a critical
component in the stimulation of glucose transport by insulin, it is
also likely that the pathway will not be suf®cient for insulin action,
as glucose transport also requires the activation of PI(3)K and
downstream protein kinases. To examine this issue, we evaluated the
impact of TC10 activation on glucose transport by overexpressing
C3G in 3T3L1 adipocytes. We transfected cells with C3G as above,
and assessed the dose dependence of insulin-stimulated glucose
transport. Insulin stimulated glucose uptake in 3T3L1 adipocytes,
with an EC50 (effector concentration at half-maximal response) of
about 0.2 nM (Fig. 5a). Expression of C3G resulted in a 4±5-fold
leftward shift of the dose±response curve, without any change in
the maximal response. This increase in insulin sensitivity suggests
that the TC10 pathway has an important role in insulin signal
transduction.
Previous studies have shown that expression of a constitutively
active PI(3)K catalytic subunit only results in a partial translocation
of GLUT4 (refs 18±20). As TC10 activation occurs independently of
PI(3)K, we examined whether these two pathways together are
suf®cient to stimulate GLUT4 translocation fully (Fig. 5b). As
typically observed, in the basal state roughly 20% of GLUT4±
EGFP-expressing cells displayed a plasma-membrane ¯uorescence,
which increased to 80% after insulin stimulation. Consistent with
previous reports18,19, co-expression of GLUT4±EGFP with a con-
stitutively active p110 (p110CAAX) resulted in partial GLUT4
translocation that was further stimulated on the addition of
insulin. Overexpressing C3G alone did not affect translocation
in the basal state, in agreement with glucose transport data (see
Fig. 5a); however, overexpressing both C3G and active p110
resulted in 75% of the transfected cells displaying the GLUT4
translocation, which is essentially identical to that induced by
insulin. The ability of C3G and p110CAAX to mimic in full the
effect of insulin strongly suggests that the combination of these
two pathways is suf®cient to mediate insulin-stimulated GLUT4
translocation.
These observations lead us to propose a new model for the spatial
compartmentalization of signals that regulate glucose transport in
adipocytes (Supplementary Information Fig. 8). The insulin recep-
tor can catalyse the tyrosine phosphorylation of a number of
substrates, including Cbl and the insulin receptor substrate (IRS)
family. On tyrosine phosphorylation, IRS proteins can interact with
PI(3)K, leading to the localized generation of phosphatidylinositol
trisphosphate (InsP3) and the subsequent activation/localization of
InsP3-dependent protein kinases. In parallel, a second pathway is
activated by the insulin receptor through the tyrosine phosphoryla-
tion of Cbl. The tyrosine-phosphorylated Cbl protein, complexed
with the adapter protein CAP, translocates to a lipid raft subdomain
in the plasma membrane; the C-terminal domain of CAP binds Cbl,
while the N-terminal domain speci®cally interacts with the lipid
raft-localized protein, ¯otillin. The tyrosine phosphorylation of Cbl
directs its association with the CrkII±C3G complex, resulting in its
co-recruitment to the lipid raft. Because TC10 is also localized in

































































Figure 5 Overexpression of C3G and constitutively active p110 in 3T3L1 adipocytes
mimics the effect of insulin on GLUT4 translocation. a, 3T3-L1 adipocytes were
transfected by electroporation with LacZ, CAP or C3G containing constructs. [14C]2-
deoxyglucose uptake was measured after exposure to various doses of insulin. Fold
stimulation by insulin is calculated as the insulin-stimulated level divided by the basal
value. Each point was performed in triplicate; means 6 s.e. are shown. b, 3T3-L1
adipocytes were transfected with 25 mg of GLUT4±EGFP, either alone or with 200 mg
C3G or 200 mg p110CAAX (a gift from A. Klippel), or with a combination of both
p110CAAX and C3G. Cells were incubated in the absence or presence of 100 nM insulin
(Ins) for 30 min. The number of cells displaying plasma-membrane rim ¯uorescence was
then determined. Values are mean 6 s.e. from three independent experiments in which
75±100 individual cells were counted.
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proximity to catalyse the exchange of GTP for GDP, resulting in the
activation of TC10.
How does TC10 affect glucose transport? Our data lead us to
speculate that TC10 may mediate the activation of two separate
downstream pathways by insulin. Insulin-activated TC10 might
directly produce a cytoskeletal rearrangement to facilitate the
exocytosis of GLUT4. Evidence suggests that actin ®laments may
have a crucial role in the exocytotic recruitment of GLUT4 to
the plasma membrane from an intracellular pool in isolated
adipocytes25. Alternatively, TC10 might be crucial in the regulation
of GLUT4 docking and fusion with the plasma membrane. Insulin
can modulate the binding of the vesicle-SNARE protein VAMP2
with the target-SNARE syntaxin 4 to control the docking and fusion
of GLUT4 vesicles through a PI(3)K-independent pathway. Thus, it
is tempting to speculate that the activation of TC10 is directly
upstream of this event. Future studies will be needed to address
these possibilities. M
Methods
Transfection of CHO/IR and 3T3L1 adipocytes
CHO/IR cells and differentiated 3T3L1 adipocytes were transiently transfected as
described1,10.
Guanine nucleotide exchange assay
We transfected 293T cells with Myc±C3G or Flag±SOS plasmid DNA. Transfected cells
were cultured for 48 h, gathered and lysed in 25 mM HEPES pH 7.4, 150 mM NaCl,
1.5 mM MgCl2, 0.5% Triton X-100 and protease inhibitors. Myc±C3G and Flag±SOS
proteins were immunoprecipitated with Myc antibody or Flag antibodies and protein-A/
G±Sepharose. Guanine nucleotide exchange assays were performed essentially as
described26. We constructed C3G and C3GDcdc25 by cloning the NcoI±XbaI and
NcoI±SmaI fragments, respectively, of the coding sequence of C3G into a pCS2-mt vector
with a 59 Myc epitope tag.
Af®nity precipitation of TC10 using GST±Pak1 PBD
We modi®ed the method from ref. 15. Cells were incubated with binding buffer (25 mM
Tris-HCl, pH 7.5, 1 mM dithiothreitol, 30 mM MgCl2, 40 mM NaCl and 0.5% Nonidet
P-40) in the presence of 7 mg of GST±Pak1 pzi-binding domain (PBD) agarose (Upstate)
for 1 h at 4 8C. The beads were washed three times with 1% Nonidet P-40 washing buffer.
The beads were suspended in sample buffer, separated by 4±20% SDS±PAGE, transferred
to a nitrocellulose membrane, and blotted with anti-HA monoclonal antibody.
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Migration is a basic feature of many cell types in a wide range of
species1. Since the 1800s, cell migration has been proposed to
occur in the nervous and immune systems2,3, and distinct mo-
lecular cues for mammalian neurons and leukocytes have been
identi®ed. Here we report that Slit, a secreted protein previously
known for its role of repulsion in axon guidance and neuronal
migration, can also inhibit leukocyte chemotaxis induced by
chemotactic factors. Slit inhibition of the chemokine-induced
chemotaxis can be reconstituted by the co-expression of a
chemokine receptor containing seven transmembrane domains
and Roundabout (Robo), a Slit receptor containing a single
transmembrane domain. Thus, there is a functional interaction
between single and seven transmembrane receptors. Our results
reveal the activity of a neuronal guidance cue in regulating
leukocyte migration and indicate that there may be a general
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